Dr. Paolo Ingallinella | Diagnostics | Best Researcher Award

Dr. Paolo Ingallinella | Diagnostics | Best Researcher Award

Diasorin | Italy

Dr. Paolo Nunzio Ingallinella is a distinguished biotech director at Diasorin Italia Spa, with over many years of expertise in peptide and protein chemistry for therapeutic and diagnostic applications. he holds a master’s degree in chemistry from the university of naples and began his career at irbm, where he contributed to groundbreaking antiviral research, developing potent hcv peptide inhibitors and an hiv fusion inhibitor that advanced antiviral drug design. He has been leading innovative diagnostic projects at diasorin, including the development of the first automated immunoassays for hdv and hev antibodies and Diagnostics broad-spectrum legionella antigen detection systems. his extensive research portfolio includes 25 completed or ongoing projects, 23 journal publications indexed, and 20 patents published or under process. According to scopus metrics, Dr. Ingallinella has an h-index of 19 with a total of 1,616 citations, reflecting his strong influence in the biotechnology and immunodiagnostics fields. his work focuses on recombinant protein and monoclonal antibody development, biomarker discovery, and molecular biology applications in diagnostics and therapeutic peptide chemistry. A member of the Italian peptide society, Dr. Ingallinella continues to shape the landscape of modern biotechnology through innovation and scientific leadership.

Profile: Scopus

Featured Publications

Ingallinella, P. N., et al. (2025). The LIAISON® Legionella Urinary Ag assay: A novel high-throughput, fully automated dual-antigen detection method with improved sensitivity and expanded Legionella species and serogroup coverage. Respiratory Investigation.

Ingallinella, P. N., et al. (2014). Development of a neuromedin U–human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes: Comparison with the PEGylated peptide. Journal of Peptide Science.

Ingallinella, P. N., et al. (2013). A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic, and anorexigenic activity. Bioorganic & Medicinal Chemistry.

Ms. Siona Prasad | Automated Early VTE Detection | Best Researcher Award

Ms. Siona Prasad | Automated Early VTE Detection | Best Researcher Award

Harvard Medical School | United States

Ms. Siona Prasad is a dedicated medical researcher and md candidate at harvard medical school, boston, massachusetts, pursuing her degree through the pathways program with an expected graduation. She graduated summa cum laude from harvard university with an a.b. in computer science and global health & health policy. Her academic and research journey reflects a strong interdisciplinary blend of medicine, data science, and global health innovation. with a research portfolio spanning prestigious institutions such as brigham and women’s hospital, mass general brigham, and boston children’s hospital, dr. prasad has contributed to advancements in cardiovascular risk prediction, ai-driven diagnostics, and digital health innovation. Her notable projects include developing machine learning algorithms for early disease detection and ai-powered diagnostic tools, Automated early VTE detection highlighting her expertise at the intersection of healthcare and technology. her scholarly work has been cited 9 times across 6 published documents, demonstrating growing recognition within the academic community, and she holds an h-index of 3, reflecting the impact and relevance of her contributions to biomedical research. driven by a vision to integrate artificial intelligence into clinical decision-making, dr. siona prasad continues to shape the future of computational medicine and global health equity.

Profiles: Scopus | Orcid

Featured Publications

Prasad, S., Dykes, P. C., Schreiber, R., Hijjawi, S., Nawab, K., Kim, A., Lipsitz, S., Syrowatka, A., Samal, L., Bates, D. W., et al. (2025). Development of an algorithm for estimating the likelihood of venous thromboembolism in primary care using structured and unstructured electronic health record data. American Journal of Hematology. Advance online publication.

Rao, A. S., Prasad, S., Lee, R. S., Farrell, S., McKinley, S., & Succi, M. D. (2025). Development and evaluation of an artificial intelligence–powered surgical oral examination simulator: A pilot study. Mayo Clinic Proceedings: Digital Health. Advance online publication.

Alayande, B. T., Pai, M., Prasad, S., Abimpaye, M., Bakorimana, L., Niyigena, A., Nkurunziza, J., Cubaka, V. K., Kateera, F., Fletcher, R., et al. (2023). Image-based surgical site infection algorithms to support home-based post-cesarean monitoring: Lessons from Rwanda. PLOS Global Public Health, 3(2), e0001584.

Prasad, S. (2022, May). Robustness of a visible image machine learning surgical site infection diagnostic algorithm when image quality is degraded. Presented at the Rwanda Health Research and Policy Symposium.

Prasad, S. (2022, April 8). Urban inversions of air pollution sources/sinks and uncertainty quantification to pinpoint determinants of poor air quality. Presented at the Joint Mathematics Meeting.